ER-α plays a major role in different steps (initiation and proliferation) of breast cancer, in that it up-regulates the expression of oncoproteins, whereas it down-regulated the levels of cell cycle inhibitors, such as P21 [103,104]. This evidence concerns the gene ESR1 and breast cancer.